Pharmacy :: Pharmacy profession will have new regulatory body in UK
Historic changes to the regulation of the pharmacy profession announced earlier this year have been endorsed by an independent working party.
Pharmaceutical
COPD :: Neglected global epidemic of chronic obstructive lung disease
Chronic obstructive pulmonary disease (COPD) is a major and increasing global health epidemic that has received insufficient attention from the health-care profession, governments, and the pharmaceutical industry, argues Professor Peter Barnes, one of the world’s leading experts on lung disease.
Drug :: Prescribed drug spending growing faster in Canada
Spending on prescribed drugs in Canada is estimated to have reached $21.1 billion in 2006, an increase of $1.4 billion over the previous year, according to figures released by the Canadian Institute for Health Information (CIHI) in its annual report on drug spending.
Tea :: When is a cup of tea a pharmaceutical?
When is an herbal tea a safe and effective sleep aid, and when is that same tea a risky pharmaceutical choice? Health care professionals face such questions daily, and a University of Arkansas researcher cautions that they may need to acquire advanced clinical skills in order to assure patient safety.
Stem Cell :: State seeds stem cell company based on UW-Madison research
Governor Jim Doyle gave a $1 million boost to a University of Wisconsin-Madison spin-off company during a visit to the campus lab that gave birth to its technology.
Asthma :: Cost and locality, barriers to proper asthma medication use
A report released by the Australian Institute of Health and Welfare suggests that some asthma medications are not being used in the optimal way by most people.
Cancer :: Teva Announces Tentative Approval of Generic Gemzar for Injection
Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced that the U.S. Food and Drug Administration has granted tentative approval for the Company’s Abbreviated New Drug Application (ANDA) to market its generic version of Eli Lilly and Co’s cancer treatment Gemzar? (Gemcitabine) for injection, 200 mg base/vial.
Antibiotic :: Teva Announces Approval and Shipment of Generic Omnicef Capsules and POS
Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced that the U.S. Food and Drug Administration has granted approval for the Company’s Abbreviated New Drug Applications (ANDA) to market its generic versions of Abbott’s antibiotic Omnicef? (Cefdinir) Capsules, 300 mg, and for Oral Suspension, 125 mg/5 mL and 250 mg/5 mL. Teva has commenced shipment of these products.
GERD :: Teva Provides Update on Generic Aciphex Litigation
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA)announced that the U.S. District Court for the Southern istrict of New York has issued a decision in its litigation over the Company’s Abbreviated New Drug Application (ANDA) to market its generic version of Eisai’s acid pump inhibitor Aciphex? (Rabeprazole Sodium) Tablets, 20 mg.
Heart :: Scientists from the CIMA from the University of Navarra investigate a molecule for diagnosing hypertensive cardiopathy
Scientists from the Center for Applied Medical Research (CIMA) from the University of Navarra investigate whether cardiotrophin 1, a molecule that can be measured in blood, can be used as a diagnostic marker for hypertensive cardiopathy.